Building an Effective, Diverse Board Across Growth Stages

March 25, 2026 – Board composition is no longer a static exercise but a dynamic process that must keep pace with the company’s trajectory. As organizations progress through different stages of growth, the expectations placed on directors expand, requiring a deliberate and forward-looking approach to how boards are structured and refreshed.

In the realm of corporate governance, having an effective board of directors is crucial for strategic guidance, accountability, and stakeholder protection, according to a recent report from Prestige Scientific.

As a life sciences company transitions from early-stage discovery to late-stage commercialization, the firm explained that the board must evolve to meet changing needs. Prestige Scientific offers some considerations for strategically building and maintaining a diverse and effective board throughout these stages.

Diversity in Board Composition

Prestige Scientific said to the think about how diversity on a board goes beyond demographics like gender and ethnicity, encompassing a range of professional experiences, industry knowledge, functional expertise, educational backgrounds, and global perspectives. The firm notes that a diverse board can:

• Enhance Decision-Making: Different viewpoints can lead to thorough discussions and well-rounded decisions.

• Reflect Stakeholder Interests: A board that mirrors its stakeholders can better understand and address their needs.

• Drive Innovation: Diverse backgrounds encourage creativity and openness to new ideas.

Building an Effective Board

1. Define Board Competencies: “Consider the skills, experiences, and attributes needed to support the company’s strategic goals at each stage,” the Prestige Scientific report said. “For biotech companies, this includes expertise in clinical development, regulatory affairs, commercialization, and market access.”

2. Recruitment and Selection: Think about expanding the candidate pool to include individuals with diverse backgrounds and expertise, the Prestige Scientific report explained. “Utilize professional networks, industry associations, and specialized recruitment firms,” it said. “Look for candidates experienced in discovery, clinical, and commercial phases.”

3. Promote Inclusive Practices: Foster a boardroom culture where all directors feel valued and respected, the Prestige Scientific report noted. Encourage open dialogue and the exchange of diverse viewpoints.

4. Board Evaluation and Succession Planning: Prestige Scientific also says to regularly assess board performance and plan for succession to ensure continuity and diversity in future board members.

5. Continuous Development: Lastly, Prestige Scientific explained to provide ongoing education and professional development opportunities for directors to enhance their skills and stay current with industry trends and best practices.

Evolution of Board Focus from Early to Late Stage

“As your company evolves into later stages of development, continually assess the skills or skill gaps of your current board,” the Prestige Scientific report said. The firmed offered a look at both early stage and late stage examples:

• Early Stage: Composition: Typically includes founders, early investors, and scientific advisors. Focus: Scientific validation, early-stage research, securing initial funding. Governance: A hands-on approach with tactical guidance and support.

• Late Stage: Composition: Add experienced industry professionals, financial experts, and regulatory/compliance experts. Focus: Commercialization, market entry, operational scaling. Governance: Strategic oversight, risk management, and long-term planning.

Considering Patient Populations

In addition to the traditional governance considerations, the composition of the board should also reflect an understanding of the patient populations the company serves, the Prestige Scientific report explained. The noted that this can be addressed these ways:

• Incorporating Patient Advocates: Including individuals who have a direct connection or experience with the patient populations your biotech company serves can provide invaluable insights.

• Understanding Patient Needs: Ensuring board members are knowledgeable about the specific needs, challenges, and experiences of the patient populations.

• Ethical and Inclusive Practices: Promoting ethical standards and inclusive practices that prioritize patient welfare and address health disparities.

Benefits of a Diverse Board

• Improved Governance and Risk Management: Diverse boards are better equipped to oversee risk management and compliance.

• Enhanced Reputation and Stakeholder Trust: Demonstrating a commitment to fairness and ethical leadership can enhance corporate reputation and stakeholder trust.
• Better Performance and Financial Outcomes: Research indicates that companies with diverse boards tend to outperform their peers financially.

“Building an effective board with appropriate diversity of skills and backgrounds is not just a compliance exercise but a strategic imperative for modern organizations,” the Prestige Scientific report concluded. “For biotech companies, this is especially important as they navigate the distinct challenges and opportunities at each stage of development. By leveraging the collective expertise and perspectives of directors from diverse professional and personal backgrounds, boards can navigate challenges more effectively, drive innovation, and capitalize on emerging opportunities.”

“Embracing diversity in board composition strengthens corporate governance, enhances stakeholder engagement, and ultimately contributes to the long-term success and sustainability of the organization in a rapidly evolving global marketplace,” the Prestige Scientific report said. “As you prepare to evolve your board, keep these considerations in mind to ensure you’re building a team that can guide your company through each stage of growth and change. Ensuring the board reflects and understands the patient populations you serve will further enhance the company’s ability to innovate and deliver impactful solutions.”

Founded in 2001, Prestige Scientific is an executive search firm that builds innovative leadership teams in life sciences, from discovery through commercial. The firm provides clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. Based in Milford, MA, Prestige Scientific has more than 200 pharmaceutical and biotechnology clients. The firm has completed 1,000 searches in 20 states and eight countries.

Related: The Future of Healthcare Leadership: Navigating AI, Innovation, and Talent Demands

Contributed by Scott A. Scanlon, Editor-in-Chief and Dale M. Zupsansky, Executive Editor  – Hunt Scanlon Media